Friday 6 November 2026
Export XXII’s income statement to Excel — free account
22nd Century Group, Inc
XXII Consumer Defensive Tobacco
22nd Century Group, Inc’s revenue for fiscal 2025 (year ended December 2025) was $17.6 million, down 27.9% from fiscal 2024.
- Revenue
- −29.9%
- EPS
- +96.9%
- Free cash flow
- −57.4%
- Total debt
- −88.6%
Quarter to June 2026, against a year earlier
1.68
0.25
−12.95%
Follow XXII
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 4 | 3 | 2 |
| (86.02%) | (98.46%) | (130.19%) | (284.50%) | ||
| (32.09%) | (39.97%) | (62.47%) | (142.23%) | ||
ROIC |
(49.42%) | (61.02%) | (61.92%) | (59.22%) | |
Return on Tangible Assets |
(63.34%) | (76.05%) | (104.13%) | (266.38%) | |
Average Days of Receivables |
60.46 | 74.59 | 110.85 | 89.89 | |
Free Cash Flow per Share |
(1,206.78) | (850.87) | (266.54) | (45.51) | |
Free Cash Flow |
(14.24) | (7.83) | (7.94) | (9.52) | |
Capital Expenditures |
0.63 | (0.10) | (0.09) | (1.16) | |
| Other line items | |||||
Cash ROIC |
(54.87%) | (29.94%) | (25.43%) | (37.86%) | |
Accounts Receivable Turnover |
7.57 | 6.65 | 3.46 | 4.08 | |
Accounts Payable Turnover |
7.59 | 12.19 | 9.19 | 9.68 | |
Inventory Turnover |
8.24 | 6.54 | 5.48 | 4.93 | |
Average Days of Payables |
43.85 | 17.61 | 19.80 | 14.63 | |
Days of Inventory on Hand |
49.05 | 76.19 | 83.93 | 95.49 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4.43% | 3.91% | 5.15% | 6.05% | |
Selling, General and Administrative Expense of Revenue |
45.61% | 43.16% | 50.27% | 58.51% | |
Share Based Compensation of Revenue |
2.06% | 2.39% | 4.02% | 5.48% | |
Interest Coverage |
(7.52) | (7.95) | (13.25) | (21.51) | |
Operating CF/Net income |
1.58 | 0.79 | 0.49 | 0.24 | |
Depreciation/Fixed assets |
0.49 | 0.47 | 0.47 | 0.41 | |
Capex/Depreciation |
0.52 | (0.09) | (0.08) | (1.10) | |
Revenue per Share |
1,531.36 | 1,911.63 | 528.05 | 69.39 | |
Operating CF per Share |
(1,260.17) | (839.46) | (263.42) | (39.97) | |
Capex per Share |
53.39 | (11.41) | (3.12) | (5.54) | |
Capex to Sales |
(0.03) | 0.01 | 0.01 | 0.08 |
Columns are period end dates · fundamentals updated 26 Oct 2026